Last reviewed · How we verify

Cyclophosphamide, Azathioprine,prednisone,methylprednisolone

Assistance Publique - Hôpitaux de Paris · FDA-approved active Small molecule

Cyclophosphamide, Azathioprine,prednisone,methylprednisolone is a Immunosuppressive combination therapy Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently FDA-approved for Severe systemic lupus erythematosus (SLE), Severe vasculitis, Severe autoimmune conditions refractory to conventional therapy.

This combination regimen suppresses the immune system through multiple pathways: cyclophosphamide and azathioprine inhibit lymphocyte proliferation, while corticosteroids (prednisone and methylprednisolone) broadly suppress inflammatory and immune responses.

This combination regimen suppresses the immune system through multiple pathways: cyclophosphamide and azathioprine inhibit lymphocyte proliferation, while corticosteroids (prednisone and methylprednisolone) broadly suppress inflammatory and immune responses. Used for Severe systemic lupus erythematosus (SLE), Severe vasculitis, Severe autoimmune conditions refractory to conventional therapy.

At a glance

Generic nameCyclophosphamide, Azathioprine,prednisone,methylprednisolone
SponsorAssistance Publique - Hôpitaux de Paris
Drug classImmunosuppressive combination therapy
ModalitySmall molecule
Therapeutic areaImmunology
PhaseFDA-approved

Mechanism of action

Cyclophosphamide is an alkylating agent that cross-links DNA and preferentially depletes B and T lymphocytes. Azathioprine is a purine analog that inhibits nucleotide synthesis and lymphocyte proliferation. Corticosteroids inhibit cytokine production and immune cell activation. Together, these agents provide potent immunosuppression used in severe autoimmune and inflammatory conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Cyclophosphamide, Azathioprine,prednisone,methylprednisolone

What is Cyclophosphamide, Azathioprine,prednisone,methylprednisolone?

Cyclophosphamide, Azathioprine,prednisone,methylprednisolone is a Immunosuppressive combination therapy drug developed by Assistance Publique - Hôpitaux de Paris, indicated for Severe systemic lupus erythematosus (SLE), Severe vasculitis, Severe autoimmune conditions refractory to conventional therapy.

How does Cyclophosphamide, Azathioprine,prednisone,methylprednisolone work?

This combination regimen suppresses the immune system through multiple pathways: cyclophosphamide and azathioprine inhibit lymphocyte proliferation, while corticosteroids (prednisone and methylprednisolone) broadly suppress inflammatory and immune responses.

What is Cyclophosphamide, Azathioprine,prednisone,methylprednisolone used for?

Cyclophosphamide, Azathioprine,prednisone,methylprednisolone is indicated for Severe systemic lupus erythematosus (SLE), Severe vasculitis, Severe autoimmune conditions refractory to conventional therapy.

Who makes Cyclophosphamide, Azathioprine,prednisone,methylprednisolone?

Cyclophosphamide, Azathioprine,prednisone,methylprednisolone is developed and marketed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).

What drug class is Cyclophosphamide, Azathioprine,prednisone,methylprednisolone in?

Cyclophosphamide, Azathioprine,prednisone,methylprednisolone belongs to the Immunosuppressive combination therapy class. See all Immunosuppressive combination therapy drugs at /class/immunosuppressive-combination-therapy.

What development phase is Cyclophosphamide, Azathioprine,prednisone,methylprednisolone in?

Cyclophosphamide, Azathioprine,prednisone,methylprednisolone is FDA-approved (marketed).

What are the side effects of Cyclophosphamide, Azathioprine,prednisone,methylprednisolone?

Common side effects of Cyclophosphamide, Azathioprine,prednisone,methylprednisolone include Infection (bacterial, viral, fungal), Bone marrow suppression/leukopenia, Hemorrhagic cystitis, Nausea and vomiting, Alopecia, Hyperglycemia.

Related